|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 117 out of 117 for Ang2

<< First    < Previous  |  Next >    Last >>
0.018s
Type Details Score
Publication
First Author: Nambu H
Year: 2005
Journal: J Cell Physiol
Title: Angiopoietin 1 prevents retinal detachment in an aggressive model of proliferative retinopathy, but has no effect on established neovascularization.
Volume: 204
Issue: 1
Pages: 227-35
Publication
First Author: Shimoda H
Year: 2009
Journal: Histochem Cell Biol
Title: Immunohistochemical demonstration of Angiopoietin-2 in lymphatic vascular development.
Volume: 131
Issue: 2
Pages: 231-8
Publication
First Author: Falcón BL
Year: 2009
Journal: Am J Pathol
Title: Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.
Volume: 175
Issue: 5
Pages: 2159-70
Publication
First Author: Pietilä R
Year: 2012
Journal: J Cell Sci
Title: Ligand oligomerization state controls Tie2 receptor trafficking and angiopoietin-2-specific responses.
Volume: 125
Issue: Pt 9
Pages: 2212-23
Publication
First Author: He T
Year: 2014
Journal: J Pathol
Title: MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.
Volume: 232
Issue: 5
Pages: 499-508
Publication
First Author: Shen J
Year: 2014
Journal: J Clin Invest
Title: Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.
Volume: 124
Issue: 10
Pages: 4564-76
Publication
First Author: Gengenbacher N
Year: 2021
Journal: Cancer Discov
Title: Timed Ang2-Targeted Therapy Identifies the Angiopoietin-Tie Pathway as Key Regulator of Fatal Lymphogenous Metastasis.
Volume: 11
Issue: 2
Pages: 424-445
Publication  
First Author: Korhonen EA
Year: 2022
Journal: J Clin Invest
Title: Lymphangiogenesis requires Ang2/Tie/PI3K signaling for VEGFR3 cell-surface expression.
Volume: 132
Issue: 15
Publication
First Author: Holopainen T
Year: 2012
Journal: J Natl Cancer Inst
Title: Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.
Volume: 104
Issue: 6
Pages: 461-75
Publication
First Author: Daley SK
Year: 2019
Journal: Inflamm Bowel Dis
Title: Role of Lymphatic Deficiency in the Pathogenesis and Progression of Inflammatory Bowel Disease to Colorectal Cancer in an Experimental Mouse Model.
Volume: 25
Issue: 12
Pages: 1919-1926
Publication
First Author: van Tuyl M
Year: 2007
Journal: Dev Biol
Title: Angiogenic factors stimulate tubular branching morphogenesis of sonic hedgehog-deficient lungs.
Volume: 303
Issue: 2
Pages: 514-26
Publication
First Author: Abbott BD
Year: 2000
Journal: Dev Dyn
Title: Placental defects in ARNT-knockout conceptus correlate with localized decreases in VEGF-R2, Ang-1, and Tie-2.
Volume: 219
Issue: 4
Pages: 526-38
Publication
First Author: Cai Q
Year: 2012
Journal: Dev Biol
Title: Enhanced expression of VEGF-A in β cells increases endothelial cell number but impairs islet morphogenesis and β cell proliferation.
Volume: 367
Issue: 1
Pages: 40-54
Publication
First Author: Mathiyalagan P
Year: 2017
Journal: Circ Res
Title: Angiogenic Mechanisms of Human CD34+ Stem Cell Exosomes in the Repair of Ischemic Hindlimb.
Volume: 120
Issue: 9
Pages: 1466-1476
Publication
First Author: Ito R
Year: 2022
Journal: Am J Physiol Lung Cell Mol Physiol
Title: SM22α cell-specific HIF stabilization mitigates hyperoxia-induced neonatal lung injury.
Volume: 323
Issue: 2
Pages: L129-L141
Publication  
First Author: Balne PK
Year: 2021
Journal: Exp Eye Res
Title: The functional role of decorin in corneal neovascularization in vivo.
Volume: 207
Pages: 108610
Publication  
First Author: Bourdeau A
Year: 2016
Journal: BMC Res Notes
Title: Vasculotide, an Angiopoietin-1 mimetic, ameliorates several features of experimental atopic dermatitis-like disease.
Volume: 9
Pages: 289